Ocular Pharmacokinetics Profile of Different Hydrocortisone Ophthalmic Formulations

Acta Ophthalmologica - United States
doi 10.1111/aos.13972_50
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Ocular Pharmacokinetics of Bimatoprost Formulated in DuraSite Compared to Bimatoprost 0.03% Ophthalmic Solution in Pigmented Rabbit Eyes

Clinical Ophthalmology
Ophthalmology
2013English

Pharmacokinetics of Three Oral Formulations of Ciprofloxacin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Control of Transdermal Permeation of Hydrocortisone Acetate From Hydrophilic and Lipophilic Formulations

AAPS PharmSciTech
EvolutionEcologySystematicsCrop ScienceAquatic ScienceBehaviorPharmaceutical ScienceMedicineAgronomyDrug Discovery
2008English

Alterations of Ocular Hemodynamics Impair Ophthalmic Vascular and Neuroretinal Function

American Journal of Pathology
Forensic MedicinePathology
2018English

Prevalence of Symptoms of Ocular Surface Disease in Patients of Ophthalmic Practices

Gaceta Medica de Mexico
Medicine
2019English

Assessment of Dissolution Profile of Marketed Aceclofenac Formulations

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2010English

Tubadil in Ophthalmic Surgery: Its Effect on Intra-Ocular Pressure

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1959English

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections

Drugs in R and D
Pharmacology
2012English

Effect of a New Ophthalmic Hydrocortisone and Sodium Hyaluronate Formulation on Two Experimental Dry Eye Models

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy